Brachial artery vasodilator function and systemic inflammation in the framingham offspring study

Circulation

Volumn 110, Issue 23, 2004, Pages 3604-3609

  Vita, Joseph A ^a,d   Keaney Jr , John F ^a   Larson, Martin G ^a,c   Keyes, Michelle J ^c   Massaro, Joseph M ^c   Lipinska, Izabella ^a   Lehman, Birgitta T ^c   Fan, Shuxia ^c   Osypiuk, Ewa ^c   Wilson, Peter W F ^c   Vasan, Ramachandran S ^a,c   Mitchell, Gary F ^b   Benjamin, Emelia J ^a,c  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CARDIOVASCULAR ENGINEERING INC   (United States)

^c NHLBI's Framingham Study   (United States)

^d BOSTON MEDICAL CENTER   (United States)

Author keywords

Atherosclerosis; Cardiovascular diseases; Endothelium; Inflammation; Risk factors

Indexed keywords

C REACTIVE PROTEIN; CELL MARKER; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1;

ADRENERGIC SYSTEM; ADULT; AGED; ARTERY BLOOD FLOW; ARTERY DILATATION; ARTICLE; BLOOD VESSEL FUNCTION; BRACHIAL ARTERY; CARDIOVASCULAR INFLAMMATION; CELL FUNCTION; CONTROLLED STUDY; CORONARY RISK; CORRELATION ANALYSIS; ENDOTHELIUM CELL; FEMALE; FOREARM; HUMAN; HYPEREMIA; HYPOTHESIS; MALE; MICROVASCULATURE; OBSERVATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SOLUBILITY; VASCULAR ENDOTHELIUM;

BIOLOGICAL MARKERS; BRACHIAL ARTERY; C-REACTIVE PROTEIN; CHEMOKINE CCL2; CLINICAL TRIALS; ENDOTHELIUM, VASCULAR; FEMALE; FOREARM; HUMANS; HYPEREMIA; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-6; MALE; MIDDLE AGED; VASODILATION;

EID: 20844463760     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000148821.97162.5E     Document Type: Article

References (38)

1. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med. 1999;340:115-126.
2. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105:1135-1143.
3. Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003;107:499-511.
4. Widlansky ME, Gokce N, Keaney JF Jr, et al. The clinical implications of endothelial dysfunction. J Am Coll Cardiol. 2003;42:1149-1160.
5. Verma S, Wang CH, Li SH, et al. A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation. 2002;106:913-919.
6. Vita JA, Keaney JF Jr. Endothelial function: a barometer for cardiovascular risk? Circulation. 2002;106:640-642.
7. Hingorani AD, Cross J, Kharbanda RK, et al. Acute systemic inflammation impairs endothelium-dependent dilatation in humans. Circulation. 2000;102:994-999.
8. Fichtlscherer S, Rosenberger G, Walter DH, et al. Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease. Circulation. 2000;102:1000-1006.
9. Prasad A, Zhu J, Halcox JP, et al. Predisposition to atherosclerosis by infections: role of endothelial dysfunction. Circulation. 2002;106:184-190.
10. Kannel WB, Feinleib M, McNamara PM, et al. An investigation of coronary heart disease in families: the Framingham offspring study. Am J Epidemiol. 1979;110:281-290.
11. Benjamin EJ, Larson MG, Keyes MJ, et al. Clinical correlates and heritability of endothelial function in the community: the Framingham Heart Study. Circulation. 2004;109:613-619.
12. Kannel WB, Wolf PA, Garrison RJ, eds. The Framingham Study: An Epidemiological Investigation of Cardiovascular Disease, Section 34. Bethesda, Md: National Heart, Lung, and Blood Institute; 1987. NIH publication No. 87-2703.
13. Mitchell GF, Parise H, Vita JA, et al. Local shear stress and brachial artery flow-mediated dilation: the Framingham Heart Study. Hypertension. 2004;44:134-139.
14. Keaney JF Jr, Larson MG, Vasan RS, et al. Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol. 2003;23:434-439.
15. Keaney JF Jr, Massaro JM, Larson MG, et al. Heritability and correlates of intercellular adhesion molecule-1 in the Framingham Offspring Study. J Am Coll Cardiol. 2004;44:168-173.
16. SAS Institute Inc. SAS Procedures Guide, Version 8. Cary, NC: SAS Institute; 1999.
17. Corretti MC, Anderson TJ, Benjamin EJ, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol. 2002;39:257-265.
18. Gimbrone MA Jr, Topper JN, Nagel T, et al. Endothelial dysfunction, hemodynamic forces, and atherogenesis. Ann N Y Acad Sci. 2000;902:230-239.
19. Vallance P, Collier J, Bhagat K. Infection, inflammation, and infarction: does acute endothelial dysfunction provide a link? Lancet. 1997;349:1391-1392.
20. Tan KC, Chow WS, Tam SC, et al. Atorvastatin lowers C-reactive protein and improves endothelium-dependent vasodilation in type 2 diabetes mellitus. J Clin Endocrinol Metab. 2002;87:563-568.
21. Brevetti G, Silvestro A, Di Giacomo S, et al. Endothelial dysfunction in peripheral arterial disease is related to increase in plasma markers of inflammation and severity of peripheral circulatory impairment but not to classic risk factors and atherosclerotic burden. J Vasc Surg. 2003;38:374-379.
22. Tomai F, Crea F, Gaspardone A, et al. Unstable angina and elevated C-reactive protein levels predict enhanced vasoreactivity of the culprit lesion. Circulation. 2001;104:1471-1476.
23. van Haelst PL, van Doormaal JJ, Asselbergs FW, et al. Correlates of endothelial function and their relationship with inflammation in patients with familial hypercholesterolaemia. Clin Sci (Lond). 2003;104:627-632.
24. Witte DR, Broekmans WM, Kardinaal AF, et al. Soluble intercellular adhesion molecule 1 and flow-mediated dilatation are related to the estimated risk of coronary heart disease independently from each other. Atherosclerosis. 2003;170:147-153.
25. John S, Jacobi J, Delles C, et al. Plasma soluble adhesion molecules and endothelium-dependent vasodilation in early human atherosclerosis. Clin Sci (Lond). 2000;98:521-529.
26. Dakak N, Husain S, Mulcahy D, et al. Contribution of nitric oxide to reactive hyperemia: impact of endothelial dysfunction and effect of L-arginine. Hypertension. 1998;32:9-15.
27. Tagawa T, Imaizumi T, Endo T, et al. Role of nitric oxide in reactive hyperemia in human forearm vessels. Circulation. 1994;90:2285-2290.
28. Meredith IT, Currie KE, Anderson TJ, et al. Postischemic vasodilation in human forearm is dependent on endothelium-derived nitric oxide. Am J Physiol. 1996;270:H1435-H1440.
29. Higashi Y, Sasaki S, Nakagawa K, et al. A noninvasive measurement of reactive hyperemia that can be used to assess resistance artery endothelial function in humans. Am J Cardiol. 2001;87:121-125.
30. Christensen KL. Reducing pulse pressure in hypertension may normalize small artery structure. Hypertension. 1991;18:722-727.
31. Moreau P, d'Uscio LV, Luscher TF. Structure and reactivity of small arteries in aging. Cardiovasc Res. 1998;37:247-253.
32. Tsao PS, Wang B, Buitrago R, et al. Nitric oxide regulates monocyte chemotactic protein-1. Circulation. 1997;96:934-940.
33. Terkeltaub R, Boisvert WA, Curtiss LK. Chemokines and atherosclerosis. Curr Opin Lipidol. 1998;9:397-405.
34. Mannion TC, Vita JA, Keaney JF Jr, et al. Non-invasive assessment of brachial artery endothelial vasomotor function is associated with a low level of discomfort. Vasc Med. 1998;3:263-267.
35. Herrington DM, Espeland MA, Crouse JR III, et al. Estrogen replacement and brachial artery flow-mediated vasodilation in older women. Arterioscler Thromb Vasc Biol. 2001;21:1955-1961.
36. Liu PY, Wishart SM, Celermajer DS, et al. Do reproductive hormones modify insulin sensitivity and metabolism in older men? A randomized, placebo-controlled clinical trial of recombinant human chorionic gonadotropin. Eur J Endocrinol. 2003;148:55-66.
37. Greenland P, Knoll MD, Stamler J, et al. Major risk factors as antecedents of fatal and nonfatal coronary heart disease events. JAMA. 2003;290:891-897.
38. Khot UN, Khot MB, Bajzer CT, et al. Prevalence of conventional risk factors in patients with coronary heart disease. JAMA. 2003;290:898-904.